A phase 2 multimodality trial of docetaxel/prednisone with sunitinib followed …

A phase 2 multimodality trial of docetaxel/prednisone with sunitinib followed …

This was a multi-institutional, non-blinded, single-arm phase II trial (NCT00734851) conducted through the Department of Defense Prostate Cancer Clinical Trials Consortium (DOD PCCTC) across three trial sites. Eligibility included men with prostate …

(Visited 3 times, 1 visits today)
3
Like
Save

Comments

Comments are disabled for this post.